Published in CMAJ on April 08, 2008
Epidemiology of diabetes mellitus among First Nations and non-First Nations adults. CMAJ (2010) 1.98
The error of not measuring asthma. CMAJ (2008) 1.07
Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study. PLoS One (2012) 1.05
Achieving control of asthma in preschoolers. CMAJ (2009) 1.01
Identifying patients with asthma in primary care electronic medical record systems Chart analysis-based electronic algorithm validation study. Can Fam Physician (2015) 0.83
Clinical, economic, and humanistic burden of asthma in Canada: a systematic review. BMC Pulm Med (2013) 0.83
Asthma in Canada: missing the treatment targets. CMAJ (2008) 0.79
The use of electronic alerts in primary care computer systems to identify the over-prescription of short-acting beta2-agonists in people with asthma: a protocol for a systematic review. NPJ Prim Care Respir Med (2017) 0.75
Contemporaneous International Asthma Guidelines Present Differing Recommendations: An Analysis. Can Respir J (2016) 0.75
The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med (1992) 8.53
Has the prevalence of asthma increased in children? Evidence from the national study of health and growth 1973-86. BMJ (1990) 6.08
National surveillance for asthma--United States, 1980-2004. MMWR Surveill Summ (2007) 6.05
Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev (2003) 5.77
Surveillance for asthma--United States, 1960-1995. MMWR CDC Surveill Summ (1998) 3.82
Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61
What is new since the last (1999) Canadian Asthma Consensus Guidelines? Can Respir J (2001) 2.65
The influence of age and sex on asthma admissions. JAMA (1993) 2.12
First treatment with inhaled corticosteroids and the prevention of admissions to hospital for asthma. Thorax (1998) 1.90
Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity? Am Rev Respir Dis (1993) 1.82
Regular use of inhaled corticosteroids and the long term prevention of hospitalisation for asthma. Thorax (2002) 1.81
Asthma control versus asthma severity. J Allergy Clin Immunol (1996) 1.59
Asthma quality-of-care markers using administrative data. Chest (2005) 1.49
Prevalence of asthma symptoms among adults aged 20-44 years in Canada. CMAJ (2001) 1.33
Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician (2007) 1.24
Sex difference in hospitalization due to asthma in relation to age. J Clin Epidemiol (2003) 1.14
Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol (2001) 1.09
Effective teamwork and quality of care. Med Care (2004) 1.09
Changing physician prescribing patterns through problem-based learning: an interactive, teleconference case-based education program and review of problem-based learning. Ann Allergy Asthma Immunol (2004) 1.01
Regular use of corticosteroids and low use of short-acting beta2-agonists can reduce asthma hospitalization. Chest (2005) 0.94
Prevalence of physician-diagnosed asthma in Saskatchewan, 1981 to 1990. Chest (1998) 0.93
How robust are health plan quality indicators to data loss? A Monte Carlo simulation study of pediatric asthma treatment. Health Serv Res (2003) 0.92
Impact of a criteria-based reimbursement policy on the use of respiratory drugs delivered by nebulizer and health care services utilization in Nova Scotia, Canada. Pharmacotherapy (2005) 0.90
Effects of flow sheet implementation on physician performance in the management of asthmatic patients. Fam Med (2002) 0.81
Pharmacy-specific quality indicators for asthma therapy. Res Social Adm Pharm (2005) 0.80
Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study. Lancet (2011) 2.65
Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med (2010) 2.31
Participatory health research: celebrating smoke-free homes. Can Fam Physician (2013) 2.06
Profile of physical activity levels in community-dwelling older adults. Med Sci Sports Exerc (2005) 1.58
Importance of dosimeter calibration method on nebulizer output. Ann Allergy Asthma Immunol (2005) 1.41
Nonspecific interstitial pneumonia and usual interstitial pneumonia with mutation in surfactant protein C in familial pulmonary fibrosis. Mod Pathol (2004) 1.37
Pharmacist and physician collaborative prescribing: for medication renewals within a primary health centre. Can Fam Physician (2009) 1.28
Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma. J Allergy Clin Immunol (2009) 1.23
The use of noninvasive ventilation in acute respiratory failure at a tertiary care center. Chest (2004) 1.23
The effects of an anti-CD11a mAb, efalizumab, on allergen-induced airway responses and airway inflammation in subjects with atopic asthma. J Allergy Clin Immunol (2003) 1.13
Prolonged survival in Churg-Strauss syndrome. Ann Allergy Asthma Immunol (2004) 1.07
Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses. Am J Respir Crit Care Med (2008) 1.05
Difference between dosimeter and tidal breathing methacholine challenge: contributions of dose and deep inspiration bronchoprotection. Chest (2005) 1.02
Implementation of a self-administered questionnaire to identify patients at risk for medication-related problems in a family health center. Pharmacotherapy (2006) 1.01
Pharmacist provision of primary health care: a modified Delphi validation of pharmacists' competencies. BMC Fam Pract (2012) 0.95
Designing a novel continuing education program for pharmacists: Lessons learned. Can Pharm J (Ott) (2012) 0.95
Regular use of corticosteroids and low use of short-acting beta2-agonists can reduce asthma hospitalization. Chest (2005) 0.94
Differences in respiratory symptoms and pulmonary function in children in 2 Saskatchewan communities. Ann Allergy Asthma Immunol (2004) 0.92
Regional variations in risk factors for asthma in school children. Can Respir J (2005) 0.91
Lung function and farm size predict healthy worker effect in swine farmers. Chest (2007) 0.88
Levalbuterol has not been established to have therapeutic advantage over racemic albuterol. J Allergy Clin Immunol (2002) 0.87
ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels. J Immunol (2009) 0.86
Dosimeter methacholine challenge: comparison of maximal versus submaximal inhalations. J Allergy Clin Immunol (2004) 0.85
Characteristics of pharmacists who enrolled in the pilot ADAPT Education Program: Implications for practice change. Can Pharm J (Ott) (2012) 0.84
Integrating a brief pharmacist intervention into practice: Osteoporosis pharmacotherapy assessment. Can Pharm J (Ott) (2012) 0.84
Hypersensitivity pneumonitis as a cause of airway-centered interstitial fibrosis. Ann Allergy Asthma Immunol (2007) 0.84
Efficacy and safety of mometasone furoate dry powder inhaler vs fluticasone propionate metered-dose inhaler in asthma subjects previously using fluticasone propionate. Ann Allergy Asthma Immunol (2004) 0.83
Familial interstitial pulmonary fibrosis: a large family with atypical clinical features. Can Respir J (2010) 0.82
Sonographic characteristics of presumptively normal canine medial iliac and superficial inguinal lymph nodes. Vet Radiol Ultrasound (2010) 0.82
Ocular side effects of bisphosphonates: A case report and literature review. Can Fam Physician (2010) 0.81
Nitrofurantoin-associated bronchiolitis obliterans organizing pneumonia: report of a case. Can Respir J (2008) 0.81
Nebulizer output for methacholine challenges with the KoKo Digidoser. J Allergy Clin Immunol (2005) 0.81
Normal expiratory flow rate and lung volumes in patients with combined emphysema and interstitial lung disease: a case series and literature review. Can Respir J (2011) 0.81
Sex differences in asthma, atopy, and airway hyperresponsiveness in a university population. Ann Allergy Asthma Immunol (2003) 0.81
Prevalence of chronic bronchitis in farm and nonfarm rural residents in Saskatchewan. J Occup Environ Med (2012) 0.80
Correlation between airway inflammation and loss of deep-inhalation bronchoprotection in asthma. Ann Allergy Asthma Immunol (2008) 0.80
Factors contributing to risks for pediatric asthma in rural Saskatchewan. Ann Allergy Asthma Immunol (2012) 0.80
The American Thoracic Society's spirometric criteria alone is inadequate in asthma diagnosis. Can Respir J (2006) 0.80
Past, present and future uses of methacholine testing. Expert Rev Respir Med (2012) 0.80
The role of farm operational and rural environments as potential risk factors for pediatric asthma in rural Saskatchewan. Pediatr Pulmonol (2013) 0.79
Evaluating the implementation and outcomes of the Saskatchewan Pressure Ulcer Guidelines in long-term care facilities. Ostomy Wound Manage (2007) 0.79
Occurrence of new-onset wheeze in a 3-year follow-up study of schoolchildren. Ann Allergy Asthma Immunol (2007) 0.78
Methacholine challenge methods. Chest (2008) 0.78
Refractoriness to inhaled mannitol 3 hours after allergen challenge. Ann Allergy Asthma Immunol (2013) 0.77
Seasonal fluctuations in airway responsiveness in elite endurance athletes. Can Respir J (2004) 0.77
Salbutamol tolerance to bronchoprotection: course of onset. Ann Allergy Asthma Immunol (2012) 0.77
Collaborative Cardiovascular Risk Reduction in Primary Care II (CCARP II): Implementation of a systematic case-finding process for patients with uncontrolled risk factors. Can Pharm J (Ott) (2013) 0.77
Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen. J Allergy Clin Immunol (2005) 0.77
Effect of a single dose of montelukast sodium on methacholine chloride PC20. Can Respir J (2005) 0.76
Prevalence and Risk Factors of Respiratory Symptoms in Rural Population. J Agromedicine (2015) 0.76
Duration of bronchoprotection of inhaled ipratropium against inhaled methacholine. Ann Allergy Asthma Immunol (2009) 0.76
Role of leukotriene receptor antagonists in the treatment of exercise-induced bronchoconstriction: a review. Allergy Asthma Clin Immunol (2005) 0.76
A nonsteroidal glucocorticoid receptor agonist inhibits allergen-induced late asthmatic responses. Am J Respir Crit Care Med (2015) 0.76
Allergen-induced asthma. Can Respir J (2014) 0.75
Methacholine test and the diagnosis of asthma. J Allergy Clin Immunol (2012) 0.75
Effects of ASM-024, a modulator of acetylcholine receptor function, on airway responsiveness and allergen-induced responses in patients with mild asthma. Can Respir J (2015) 0.75
Respiratory medicine in Saskatchewan: An historical perspective. Can Respir J (2015) 0.75
Acute interstitial pulmonary edema. Can Respir J (2014) 0.75
A posterior pneumothorax. Can Respir J (2013) 0.75
Deep inhalation bronchodilation and oral corticosteroids in asthma. Chest (2006) 0.75
Microscopic pulmonary tumour embolism: an unusual presentation of thymic carcinoma. Can Respir J (2002) 0.75
Histamine and methacholine challenge cut points. Ann Allergy Asthma Immunol (2010) 0.75
Formoterol thrice weekly does not result in the development of tolerance to bronchoprotection. Can Respir J (2003) 0.75
Part 5: Future vision for the pharmacy profession. Can Pharm J (Ott) (2017) 0.75
Exercise-induced hyperventilation: more common than appreciated. Ann Allergy Asthma Immunol (2012) 0.75
Characterization of the methacholine PC15. Ann Allergy Asthma Immunol (2011) 0.75
The effect of ipratropium nasal spray on bronchial methacholine challenge. Chest (2005) 0.75
Allergen challenge dose-response slope. J Allergy Clin Immunol (2008) 0.75
Farm Exposure and Atopy in Men and Women: The Saskatchewan Rural Health Study. J Agromedicine (2015) 0.75
Metastatic pulmonary urothelial carcinoma of the renal pelvis with an unusual presentation. Acta Cytol (2004) 0.75
Sonographic characteristics of presumptively normal main axillary and superficial cervical lymph nodes in dogs. Am J Vet Res (2012) 0.75
Appendix a: management committee terms of reference. Can Pharm J (Ott) (2012) 0.75
Deep inhalation bronchoprotection in asthma: correlation with airway responsiveness. J Allergy Clin Immunol (2006) 0.75
Deep inspiration avoidance and methacholine response in normal subjects and patients with asthma. Chest (2005) 0.75
Magnitude of bronchoprotection of albuterol vs methacholine: relationship to baseline airway caliber. Chest (2006) 0.75
Extrapolation of methacholine PC(20). Chest (2002) 0.75
Methacholine PC20: 1-point formula. Ann Allergy Asthma Immunol (2007) 0.75
Comparison of doubling and quadrupling methacholine concentration regimens using the tidal volume method. Ann Allergy Asthma Immunol (2011) 0.75
Anxiety-related visits to Ontario physicians following September 11, 2001. Can J Psychiatry (2003) 0.75
Part 4: Professional satisfaction and the priorities to advance the pharmacy profession. Can Pharm J (Ott) (2017) 0.75
Method of nebulizer calibration and methacholine airway responsiveness. J Allergy Clin Immunol (2004) 0.75
Asbestosis and probable microscopic polyangiitis. Can Respir J (2004) 0.75
The effect of caffeinated coffee on airway response to methacholine and exhaled nitric oxide. Respir Med (2011) 0.75
Extrapolation of allergen PC15. Ann Allergy Asthma Immunol (2008) 0.75
Deep inhalation bronchoprotection. Ann Allergy Asthma Immunol (2012) 0.75
A case report of wegener granulomatosis treated only with corticosteroids for 30 years. Ann Allergy Asthma Immunol (2003) 0.75
A comparison of 2 methods of continuous aerosol administration during methacholine challenge testing. Respir Care (2006) 0.75